Evofem Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Evofem Biosciences

15/11/2021 21:38

* Evofem Biosciences Inc  EVFM.OQ  reported a quarterly adjusted
loss of 48 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 29 cents per share.
* Revenue rose 515.8% to $1.71 million from a year ago; 
analysts expected $3.39 million. 
* Evofem Biosciences Inc's reported EPS for the quarter was a
loss of 48 cents​.
* The mean earnings estimate of analysts had risen by about 0.8%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Evofem Biosciences Inc shares had fallen by 9.3% this
quarter and lost 72.2% so far this year.
* The company reported a quarterly loss of $74.06 million.
* Wall Street's median 12-month price target for Evofem
Biosciences Inc is $3.25 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 15 at 09:38 p.m.
 ​All figures in US dollars unless otherwise stated